Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Podocan anticorps (C-Term)

L’anticorps Lapin Polyclonal anti-Podocan a été validé pour WB. Il convient pour détecter Podocan dans des échantillons de Humain. Il y a 3+ publications disponibles.
N° du produit ABIN1881665

Aperçu rapide pour Podocan anticorps (C-Term) (ABIN1881665)

Antigène

Voir toutes Podocan (PODN) Anticorps
Podocan (PODN)

Reactivité

  • 18
  • 17
  • 1
Humain

Hôte

  • 32
  • 2
Lapin

Clonalité

  • 33
Polyclonal

Conjugué

  • 15
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Podocan est non-conjugé

Application

  • 33
  • 15
  • 13
  • 13
  • 6
  • 4
  • 4
  • 3
  • 3
Western Blotting (WB)

Clone

RB40886
  • Épitope

    • 15
    • 7
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 571-602, C-Term

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogène

    This PODN antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 571-602 amino acids from the C-terminal region of human PODN.

    Isotype

    Ig Fraction
  • Indications d'application

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Date de péremption

    6 months
  • Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." dans: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

    Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." dans: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, (2009) (PubMed).

    Ross, Bruggeman, Hanss, Sunamoto, Marras, Klotman, Klotman: "Podocan, a novel small leucine-rich repeat protein expressed in the sclerotic glomerular lesion of experimental HIV-associated nephropathy." dans: The Journal of biological chemistry, Vol. 278, Issue 35, pp. 33248-55, (2003) (PubMed).

  • Antigène

    Podocan (PODN)

    Autre désignation

    PODN

    Sujet

    Negatively regulates cell proliferation and cell migration.

    Poids moléculaire

    68976

    NCBI Accession

    NP_001186009, NP_001186010, NP_001186011, NP_714914

    UniProt

    Q7Z5L7
Vous êtes ici:
Chat with us!